Medical - Products
Industry Rank
More Info
The Zacks Industry Rank assigns a rating to each of the 254 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 254), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (254 out of 254) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
The Zacks Industry Rank assigns a rating to each of the 254 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 254), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (254 out of 254) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
+1.34%
YTD Return More Info
Year to Date (YTD) Return shows the median percentage price change for the respective equally-weighted Industry since the beginning of the year.
Updated Oct 23
Sector: Medical
Performance
| Total Return % | IVV(iShares-SP500) | |
|---|---|---|
| 1 Month | 6.44 | 7.63 |
| 3 Months | 3.96 | 7.48 |
| YTD | 1.34 | 8.67 |
| 1 Year | 7.09 | 17.30 |
| 3 Years | 24.86 | 41.65 |
| 5 Years | 54.44 | 79.53 |
Medical - Products Performance
Key Metrics for
Industry Earnings
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| PE (F1) | 38.50 | 21.48 |
| PEG (Ratio) | 3.92 | 2.78 |
| Proj EPS Growth | 2.78% | -2.36% |
| Hist EPS Growth | 10.67% | 10.39% |
| Net Margin | -17.25% | 10.35% |
| Hist Sales Growth | 7.92% | 6.05% |
| Hist Dividend Growth | 0.00% | 1.45% |
Financial Ratios
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| Beta | 0.95 | 1.06 |
| ROE | -9.00 | 14.80 |
| ROA | -8.99 | 5.62 |
| ROI | -7.66 | 9.01 |
| Debt-to-Equity | 0.07 | 0.70 |
| Current Ratio | 2.91 | 1.37 |
| Cash Flow ($/share) | 0.20 | 1,991.00 |
| Price to Book | 3.42 | 1.45 |
| Price To Sales | 5.36 | 2.64 |
| Dividend Yield | 0.00% | 1.61% |